검색어: polyclonal anti t cell antibodies (영어 - 에스토니아어)

regulatory t cell
regulatoorsed t-lümfotsüüdid

increased representation of regulatory t cell subsets
regulatoorsete t-rakkude alarühmade osakaalu suurenemine

cutaneous vasculitis anaphylaxis hepatosplenic t-cell lymphoma
hepatospleeniline t- rakklümfoom

hepatosplenic t-cell lymphoma* (see 4.4)
hepatosplenaalne t-rakuline lümfoom* (vt 4.4)

a type of leukaemia, called t-cell acute lymphoblastic leukaemia.
teatud tüüpi leukeemia, mida nimetatakse t-rakuliseks ägedaks lümfoblastseks leukeemiaks.

t-cell responses were seen in roughly half of the patients without clinical sequelae.
t-rakulist vastust täheldati ligikaudu pooltel patsientidel ilma kliiniliste tagajärgedeta.

t-cell responses against aav were detected in approximately half of the subjects post therapy only.
ainult ravi järel tuvastati umbes pooltel isikutel aav vastane t-rakuline vastus.

rare postmarketing cases of hepatosplenic t-cell lymphoma have been identified in patients treated with adalimumab.
turustamisjärgselt on adalimumabiga ravitud patsientidel harva tuvastatud hepatospleenilist t- rakklümfoomi.

responses were seen in different immunophenotypes of all, including pre-b cell and t-cell.
ravivastuseid saavutati all erinevate immunofenotüüpidega, sealhulgas eel-b-rakud ja t-rakud.

ctla-4 inhibits the activity of t cells.
ctla-4 inhibeerib t-rakkude toimet.

it may also help to increase the number of t cells called cd4 cells.
ta võib ka aidata suurendada t-rakkude arvu, mida nimetatakse cd4-rakkudeks.

the concomitant administration of ceplene and il-2 therefore aims to optimise the anti-leukaemic functions of nk cells and t cells.
ceplene ja il-2 samaaegse manustamise eesmärk on seega nk-rakkude ja t-rakkude leukeemiavastase talitluse optimeerimine.

increase of t-cell counts above baseline (t-cell expansion) was observed in few patients.
Üksikutel patsientidel täheldati t-rakkude arvu suurenemist esialgsega võrreldes (t-rakkude vohamist).

patients who had both antibody-mediated rejection and t-cell-mediated rejection on the same biopsy were counted once for each category.
patsiente, kellel oli sama biopsia korral nii antikehadest kui ka t-rakkudest tingitud äratõukereaktsioon, võeti kummaski kategoorias ühe korra arvesse.

the covalent binding of prp to tetanus toxoid makes it a t-cell dependent antigen which induces a specific igg anti-prp response in infants and which elicits immune memory.
prp kovalentne side teetanusetoksoidiga teeb sellest t-rakust sõltuva antigeeni, mis tekitab imikutel spetsiifilise igg anti- prp vastuse ja toob välja immunoloogilise mälu.

as a result, belatacept blocks cd28 mediated co-stimulation of t cells inhibiting their activation.
tulemusena blokeerib belatatsept cd28 retseptori vahendatud t-rakkude kostimulatsiooni, inhibeerides nende aktivatsiooni.

in vitro, t-cells are more sensitive than b-cells to the cytotoxic effects of nelarabine.
in vitro on t-rakud nelarabiini tsütotoksilise toime suhtes tundlikumad kui b-rakud.

cetuximab also targets cytotoxic immune effector cells towards egfr- expressing tumour cells (antibody dependent cell-mediated cytotoxicity, adcc).
tsetuksimab suunab ka tsütotoksilised immuunsed efektorrakud egfriga kasvajarakkude vastu (antikehast sõltuv rakkude poolt vahendatud tsütotoksilisus, antibody dependent cell–mediated cytotoxicity – adcc).